Cardiac bridging integrator 1 gene therapy rescues chronic non-ischemic heart failure in minipigs. npj Regenerative Medicine , 2024; 9 (1) DOI: 10.1038/s41536-024-00380-0 Cite This Page : ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

Treatments for rare diseases are hard to create and expensive to deliver, but there is new hope for editing the software of ...

“Philanthropic support plays a critical role in accelerating the development of these new, transformative treatments,” said ...

In a finding with implications for one of the most promising cutting-edge medical treatments, researchers evaluated several ...

The data suggests that Hmga1, a key protein for regenerating heart cells, could be a target for gene therapies that prevent cardiac failure.

Researchers have discovered that the protein Hmga1, found in zebrafish, can repair damaged mouse hearts by reactivating ...

This study, supported by the Dutch Heart Foundation and Hartekind Foundation, marks an important step toward regenerative therapies to prevent heart failure. The findings ... "Our findings revealed ...

Tectonic Therapeutic, Inc. has seen a significant stock rally which has seen its shares nearly triple since this summer. What ...

While gene therapy has emerged as a promising alternative for treating beta-thalassemia, hematopoietic stem cell ...

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapie ...

INR:5719. virat kohli ipl runs Editas launches world's first in vivo CRISPR gene editing clinical trial Novartis and Gates Foundation collaborate to develop ...